By physician referral or invitation only

A Safety and Effectiveness Trial for Pembrolizumab Used for Advanced Tumors

To study the how well Pembrolizumab works on advanced tumors

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Sid Sheth
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Melanoma)

IRB Number

18-2523

ClinicalTrials.gov

NCT03486873

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

My UNC Chart
Find a Doctor
Accessibility
Privacy Policy
For Researchers

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.